|
RICT 2011 - Drug Discovery and Selection |
Confirmed Speakers |
| A Brief Guide to Fluorine-Protein Interactions for the Medicinal Chemist |
Dr Jérôme AMAUDRUT (ABBOTT-LABORATOIRE FOURNIER, Daix, France) |
|
| How can Computers Support Drug Discovery? In Silico Approaches for Anticipating Bioactivity Spectra, Analysing Adverse Drug Reactions and Predicting Ligand Activity Against Particular Protein Mutants |
Prof. Andreas BENDER (UNIVERSITY OF CAMBRIDGE, Cambridge, United Kingdom) |
|
| The Design, SAR and Synthesis of Novel ADAM-TS4 (Aggrecanase-1) Inhibitors for the Treatment of Osteoarthritis |
Dr Chris DE SAVI (ASTRAZENECA R&D, Boston, United States) |
|
| Synthesis of Radiolabelled Probes for Positron Emission Tomography: The Link Between Molecular Imaging and Medicinal Chemistry |
Dr Frédéric DOLLE (CEA, SERVICE HOSPITALIER FRÉDÉRIC JOLIOT, Orsay, France) |
|
| Template Assembled Functional Biomolecules : Chemistry, Characterization and Validation as a Paradigm for Tailor Made Molecular Medicine |
Prof. Pascal DUMY (ECOLE NATIONALE SUPÉRIEURE DE CHIMIE DE MONTPELLIER (ENSCM), Montpellier, France) |
|
| Proteomic Studies as a Guide in the Development of New Cyclin-dependent Kinase Inhibitors |
Prof. Hervé GALONS (SCT & PARIS DESCARTES UNIVERSITY, Paris, France) |
|
| Discovery and Lead Optimisation of a Novel Series of Highly Potent, Selective and Orally Bioavailable SYK Inhibitors |
Dr Neil GARTON (GLAXOSMITHKLINE, Stevenage, United Kingdom) |
|
| Folding Oligomers with Predictable Structures and Properties |
Dr Ivan HUC (IECB & CNRS - UNIVERSITÉ DE BORDEAUX, Bordeaux, France) |
|
| Accessing Libraries of Highly Antitumor Active Ansamycin Antibiotics by Semi- and Mutasynthesis |
Prof. Andreas KIRSCHNING (LEIBNIZ UNIVERSITY, Hannover, Germany) |
|
| The Mitotic Kinesin Eg5 as a Target for Drug Development in Cancer Chemotherapy: from Inhibitor Screening to in vivo Models |
Prof. Frank KOZIELSKI (BEATSON INSTITUTE FOR CANCER RESEARCH, Glasgow, United Kingdom) |
|
| Fragment-based Engineering of Protein-ligand Interactions Using NMR and Other Biophysical Methods : Towards Tailor-made Drugs |
Prof. Jean-Marc LANCELIN (CPE, VILLEURBANNE Cedex, France) |
|
| Discovery and Optimization of Kinase Inhibitors: Some Case Studies from GKS3β and IGF1R Inhibitors |
Dr Dominique LESUISSE (SANOFI AVENTIS, Chilly-Mazarin, France) |
|
| Ehrlich Lecture - Title to be announced |
Prof. Jean MARTINEZ (UNIVERSITY OF MONTPELLIER, Montpellier, France) |
|
| Difluoromethylbenzoxazole (DFMB)Pyrimidine Thioether Derivatives: A Novel Class of Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors |
Dr Maurice MEDEBIELLE (UNIVERSITÉ CLAUDE BERNARD LYON 1, Villeurbanne, France) |
|
| Gut-Targeted Microsomal Triglyceride Transfer Protein Inhibitors to Treat Obesity: Design, Clinical Proof of Concept and Novel Chemical Leads |
Dr Lieven MEERPOEL (JANSSEN R&D, Beerse, Belgium) |
|
| Discovery of Riociguat: A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension |
Prof. Joachim MITTENDORF (BAYER SCHERING PHARMA, Wuppertal, Germany) |
|
| Aleglitazar, a Potent and Balanced Dual PPARα/γ Agonist for the Reduction of Cardiovascular Mortality and Morbidity in Patients with Type 2 Diabetes |
Dr Peter MOHR (F. HOFFMANN-LA ROCHE, Basel, Switzerland) |
|
| New Multivalent Glyco-vaccines: Molecular Engineering of the Regiospecificity of Transglucosidases for Chemo-enzymatic Oligosaccharide Synthesis |
Prof. Pierre MONSAN (INSA, Toulouse, France) |
|
| Mentzer Lecture - DNA-Encoded Chemical Libraries: a New Tool for Drug Discovery |
Prof. Dario NERI (ETH ZÜRICH, Zürich, Switzerland) |
|
| KCC2 : a New Target for Epilepsy? |
Dr Cécile PEGURIER (UCB PHARMA, Braine-L'Alleud, Belgium) |
|
| Discovery of Potent and Selective Smoothened Inhibitors for the Treatment of Hedgehog-dependent Tumors |
Dr Stefan PEUKERT (NOVARTIS, Cambridge MA, United States) |
|
| Development of Enantiomers: the Example of Chiral Sulfoxides |
Dr Philippe PITCHEN (FOREST RESEARCH INSTITUTE, Hauppauge, United States) |
|
| Tumor Targeting Using Shiga Toxin: Syntheses and Biological Evaluations of Some Conjugates |
Dr Frédéric SCHMIDT (INSTITUT CURIE, Paris, France) |
|
| A Journey in Data and Chemical Spaces: Application to Pharmaceutical Sciences |
Dr Philippe VAYER (LABORATOIRE SERVIER, Orléans, France) |
|
| Non-Denaturing Chemical Proteomics for Protein Complex Isolation and Identification |
|
<Previous page |